Universitätsklinikum Münster

Hospital


Location: Münster, Germany (DE) DE

ISNI: 0000000405514246

ROR: https://ror.org/01856cw59

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial (2018) Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Gungor T, Kropshofer G, et al. Journal article Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy (2018) Hoffmann A, Ettle B, Battis K, Reiprich S, Schlachetzki J, Masliah E, Wegner M, et al. Journal article Publisher Correction: Nfat/calcineurin signaling promotes oligodendrocyte differentiation and myelination by transcription factor network tuning (2018) Weider M, Starost LJ, Groll K, Küspert M, Sock E, Wedel M, Fröb F, et al. Journal article, Erratum Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL (2018) Boegemann M, Bedke J, Schostak M, Welslau M, Hering-Schubert C, Wolf T, Schleicher J, et al. Conference contribution Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial (2018) Suttorp M, Schulze P, Glauche I, Goehring G, Von Neuhoff N, Metzler M, Sedlacek P, et al. Journal article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Grunewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Journal article Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial (2018) Tacke M, Borggraefe I, Gerstl L, Heinen F, Vill K, Bonfert M, Bast T, et al. Journal article ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution Advanced Prostate Cancer Consensus Conference 2017. Discussion of the recommendations for diagnosis and treatment of metastatic prostate cancer by a German panel of experts (2018) Schostak M, Koenig F, Boegemann M, Goebell P, Hammerer P, Machtens S, Schwentner C, et al. Journal article New findings regarding the neurobiology of pruritus (2018) Pereira MP, Agelopoulos K, Kremer A, Schmelz M Journal article